|

Orca-T Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Stanford University1
  • Orca Biosystems, Inc.1

Indications

  • Mixed Phenotype Acute Leukemia2
  • Myelodysplastic Syndromes2
  • Cancer2
  • Acute Lymphoid Leukemia1
  • Leukemia, Myeloid, Acute1

Los Angeles, California1 trial

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine

Phase 2

Palo Alto, California1 trial

Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.